Drugs targeting different metabolic pathways induced in tumors may be used in combination with one another to induce synthetic lethality in cancer cells, while preserving the survival of normally proliferating cells.
Adrian L. Harris, MD, PhD
Advertisement
Articles by Adrian L. Harris, MD, PhD
Advertisement
Latest Updated Articles
- Cancer Metabolism as a Therapeutic Target: Metabolic Synthetic Lethality
Published: May 15th 2013 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Novel SSTR-Targeted Alpha Therapy Shows “Encouraging” Activity in GEP-NETs
2
Radiotherapy Plus Chemoimmunotherapy Improves Frontline ES-SCLC Prognosis
3
Durvalumab Plus Concurrent CRT Does Not Add Benefit in Stage III NSCLC
4
Pembrolizumab Combo Does Not Significantly Improve OS in Unresectable HCC
5
